Insider Trading activities at Amicus Therapeutics, Inc. (FOLD)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amicus Therapeutics, Inc. (FOLD) since 2007 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amicus Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1178879.

Total stock buying since 2007: $164,927,777.
Total stock sales since 2007: $289,464,081.
Total stock option exercises since 2007: $43,076,426.


50 insiders reported insider trading activities at Amicus Therapeutics, Inc. (FOLD):
Insider trading activities of Newhall Charles W Iii
Insider trading activities of Sandell Scott D
Insider trading activities of Sblendorio Glenn
Insider trading activities of Edelman Joseph
Insider trading activities of Do Hung
Insider trading activities of Yu Julie
Insider trading activities of Trainor Iii Eugene A
Insider trading activities of Doshi Dipal
Insider trading activities of Green Jeremy
Insider trading activities of Barer Sol J
Insider trading activities of Fhm V, Lp
Insider trading activities of Barris Peter J
Insider trading activities of Fhm V, Llc
Insider trading activities of Bleil Lynn Dorsey
Insider trading activities of Whitman Burke W
Insider trading activities of Barth Jay
Insider trading activities of Perceptive Life Sciences Master Fund Ltd
Insider trading activities of Andrews Kurt J.
Insider trading activities of Kirk John
Insider trading activities of Clark David Michael
Insider trading activities of Valenzano Ken
Insider trading activities of Bloch Stephen M
Insider trading activities of Weinhoff Gregory M
Insider trading activities of Perry Mark W
Insider trading activities of Castelli Jeff
Insider trading activities of Crowley John F
Insider trading activities of Winterbottom Joan
Insider trading activities of Campbell Bradley L
Insider trading activities of Glaxosmithkline Plc
Insider trading activities of Quimi Daphne
Insider trading activities of Gershkowitz Jayne
Insider trading activities of Barrett M James
Insider trading activities of Kramlich C Richard
Insider trading activities of Topper James N
Insider trading activities of Frazier Affiliates Iv Lp
Insider trading activities of Raab Michael
Insider trading activities of Baird William D Iii
Insider trading activities of Prout Samantha
Insider trading activities of Rosenberg Ellen
Insider trading activities of Hayden Donald J Jr
Insider trading activities of Hirsch Russell C
Insider trading activities of Barkas Alexander E
Insider trading activities of Dilone Enrique
Insider trading activities of Mcglynn Margaret G
Insider trading activities of Peist Kenneth
Insider trading activities of Licholai Gregory P
Insider trading activities of Frazier Healthcare Iv Lp
Insider trading activities of Patterson Matthew R
Insider trading activities of Schaeffer Orlov S Nicole
Insider trading activities of Palling David

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Amicus Therapeutics, Inc. (FOLD).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 400 $4,000 400 $3,611
2024 0 $0 399,658 $5,124,634 182,067 $1,360,541
2023 0 $0 813,767 $10,307,679 457,240 $2,081,221
2022 0 $0 424,370 $4,449,738 116,155 $466,726
2021 45,105 $451,689 557,791 $7,173,882 411,757 $2,127,182
2020 11,000 $175,512 1,681,390 $24,511,559 1,284,060 $8,873,723
2019 4,945 $49,796 572,269 $6,783,107 547,724 $2,955,368
2018 1,235,827 $15,744,014 301,765 $4,590,161 201,765 $1,644,814
2017 1,501,395 $18,395,032 971,072 $12,606,562 913,823 $11,449,856
2016 592,950 $3,020,945 1,260,420 $8,649,277 156,358 $50,864
2015 810,000 $5,440,410 1,080,786 $13,931,432 1,273,641 $11,766,749
2014 6,467,084 $30,224,665 11,682,909 $62,446,695 16,491 $10,521
2013 1,525,000 $3,085,000 0 $0 0 $0
2012 9,361,554 $55,128,673 0 $0 49,931 $31,955
2011 30,000 $162,800 2,250 $16,875 2,250 $1,435
2010 11,898 $43,903 0 $0 0 $0
2009 20,000 $82,600 71,908 $765,927 5,924 $8,466
2008 1,834,162 $27,685,294 677,689 $127,429,143 153,582 $191,652
2007 461,042 $5,237,444 44,894 $673,410 81,102 $51,742

Table 2. Monthly summary of insider trading at Amicus Therapeutics, Inc. (FOLD).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-02 0 $0 400 $4,000 400 $3,611
2024-12 0 $0 7,500 $75,127 7,500 $64,574
2024-11 0 $0 15,401 $184,759 15,401 $161,598
2024-10 0 $0 7,500 $79,492 7,500 $64,574
2024-09 0 $0 7,500 $87,795 7,500 $64,574
2024-08 0 $0 7,500 $77,520 7,500 $64,574
2024-07 0 $0 7,500 $75,032 7,500 $64,575
2024-06 0 $0 7,500 $75,000 7,500 $64,574
2024-05 0 $0 7,500 $75,525 7,500 $64,574
2024-04 0 $0 7,500 $87,495 7,500 $64,574
2024-03 0 $0 0 $0 15,000 $42,000
2024-02 0 $0 117,655 $1,544,669 45,833 $320,175
2024-01 0 $0 206,602 $2,762,220 45,833 $320,175
2023-12 0 $0 90,936 $1,233,776 46,702 $215,003
2023-11 0 $0 17,744 $194,721 11,700 $34,398
2023-10 0 $0 23,788 $268,262 11,700 $34,398
2023-09 0 $0 30,181 $392,057 11,700 $34,398
2023-08 0 $0 68,997 $944,279 48,609 $419,469
2023-07 0 $0 32,088 $403,530 11,700 $34,398
2023-06 0 $0 32,088 $384,193 11,700 $31,531
2023-05 0 $0 23,788 $277,009 26,700 $78,465
2023-04 0 $0 23,788 $269,495 11,700 $28,665
2023-03 0 $0 48,584 $605,018 26,700 $78,465
2023-02 0 $0 173,360 $2,269,027 151,629 $814,366

Table 3. Detailed insider trading at Amicus Therapeutics, Inc. (FOLD)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-02-19 Campbell Bradley L (President and CEO) Sale 400 10.00 4,000
2025-02-19 Campbell Bradley L (President and CEO) Option Ex 400 9.03 3,611
2024-12-02 Campbell Bradley L (President and CEO) Sale 7,500 10.02 75,127
2024-12-02 Campbell Bradley L (President and CEO) Option Ex 7,500 8.61 64,574
2024-11-06 Campbell Bradley L (President and CEO) Sale 7,901 12.51 98,802
2024-11-06 Campbell Bradley L (President and CEO) Option Ex 7,901 12.28 97,024
2024-11-01 Campbell Bradley L (President and CEO) Sale 7,500 11.46 85,957
2024-11-01 Campbell Bradley L (President and CEO) Option Ex 7,500 8.61 64,574
2024-10-01 Campbell Bradley L (President and CEO) Sale 7,500 10.60 79,492
2024-10-01 Campbell Bradley L (President and CEO) Option Ex 7,500 8.61 64,574
2024-09-03 Campbell Bradley L (President and CEO) Sale 7,500 11.71 87,795
2024-09-03 Campbell Bradley L (President and CEO) Option Ex 7,500 8.61 64,574
2024-08-01 Campbell Bradley L (President and CEO) Sale 7,500 10.34 77,520
2024-08-01 Campbell Bradley L (President and CEO) Option Ex 7,500 8.61 64,574
2024-07-05 Campbell Bradley L (President and CEO) Sale 6,100 10.01 61,030
2024-07-05 Campbell Bradley L (President and CEO) Option Ex 6,100 8.61 52,521
2024-07-01 Campbell Bradley L (President and CEO) Sale 1,400 10.00 14,002
2024-07-01 Campbell Bradley L (President and CEO) Option Ex 1,400 8.61 12,054
2024-06-03 Campbell Bradley L (President and CEO) Sale 7,500 10.00 75,000
2024-06-03 Campbell Bradley L (President and CEO) Option Ex 7,500 8.61 64,574
2024-05-01 Campbell Bradley L (President and CEO) Sale 7,500 10.07 75,525
2024-05-01 Campbell Bradley L (President and CEO) Option Ex 7,500 8.61 64,574
2024-04-01 Campbell Bradley L (President and CEO) Sale 7,500 11.67 87,495
2024-04-01 Campbell Bradley L (President and CEO) Option Ex 7,500 8.61 64,574
2024-03-07 Sblendorio Glenn Option Ex 15,000 2.80 42,000
2024-02-15 Clark David Michael (Chief People Officer) Sale 4,427 14.00 61,978
2024-02-15 Crowley John F (Executive Chairman) Sale 31,614 13.81 436,557
2024-02-15 Campbell Bradley L (President and CEO) Sale 4,167 14.00 58,338
2024-02-07 Rosenberg Ellen (Chief Legal Officer) Sale 29,600 13.00 384,829
2024-02-07 Rosenberg Ellen (Chief Legal Officer) Option Ex 29,600 5.16 152,736
2024-02-06 Rosenberg Ellen (Chief Legal Officer) Sale 400 13.00 5,200
2024-02-06 Rosenberg Ellen (Chief Legal Officer) Option Ex 400 5.16 2,064
2024-02-01 Crowley John F (Executive Chairman) Sale 31,614 12.62 398,905
2024-02-01 Campbell Bradley L (President and CEO) Sale 15,833 12.56 198,862
2024-02-01 Campbell Bradley L (President and CEO) Option Ex 15,833 10.45 165,375
2024-01-22 Crowley John F (Executive Chairman) Sale 55,327 12.36 683,952
2024-01-16 Crowley John F (Executive Chairman) Sale 31,614 12.78 404,121
2024-01-10 Crowley John F (Executive Chairman) Sale 31,614 13.65 431,467
2024-01-09 Clark David Michael (Chief People Officer) Sale 1,384 14.00 19,376
2024-01-09 Prout Samantha (Chief Accounting Officer) Sale 1,337 14.00 18,718
2024-01-08 Clark David Michael (Chief People Officer) Sale 8,726 14.00 122,164
2024-01-08 Prout Samantha (Chief Accounting Officer) Sale 30,767 14.00 430,830
2024-01-02 Rosenberg Ellen (Chief Legal Officer) Sale 30,000 14.21 426,210
2024-01-02 Rosenberg Ellen (Chief Legal Officer) Option Ex 30,000 5.16 154,800
2024-01-02 Campbell Bradley L (President and CEO) Sale 15,833 14.23 225,382
2024-01-02 Campbell Bradley L (President and CEO) Option Ex 15,833 10.45 165,375
2023-12-28 Castelli Jeff (Chief Development Officer) Sale 17,421 14.52 252,900
2023-12-27 Rosenberg Ellen (Chief Legal Officer) Sale 5,000 14.06 70,325
2023-12-27 Rosenberg Ellen (Chief Legal Officer) Option Ex 5,000 5.16 25,800
2023-12-26 Prout Samantha (Chief Accounting Officer) Sale 7,659 14.00 107,226
2023-12-26 Rosenberg Ellen (Chief Legal Officer) Sale 30,000 14.00 420,090
2023-12-26 Rosenberg Ellen (Chief Legal Officer) Option Ex 30,000 5.16 154,800
2023-12-20 Castelli Jeff (Chief Development Officer) Sale 1,654 13.10 21,667
2023-12-19 Castelli Jeff (Chief Development Officer) Sale 17,500 13.25 231,875
2023-12-01 Campbell Bradley L (President and CEO) Sale 11,702 11.08 129,693
2023-12-01 Campbell Bradley L (President and CEO) Option Ex 11,702 2.94 34,403
2023-11-01 Crowley John F (Executive Chairman) Sale 6,044 10.97 66,326
2023-11-01 Campbell Bradley L (President and CEO) Sale 11,700 10.97 128,395
2023-11-01 Campbell Bradley L (President and CEO) Option Ex 11,700 2.94 34,398
2023-10-16 Crowley John F (Executive Chairman) Sale 6,044 10.50 63,449
2023-10-02 Crowley John F (Executive Chairman) Sale 6,044 11.39 68,859
2023-10-02 Campbell Bradley L (President & CEO) Sale 11,700 11.62 135,954
2023-10-02 Campbell Bradley L (President & CEO) Option Ex 11,700 2.94 34,398
2023-09-15 Crowley John F (Executive Chairman) Sale 6,044 13.06 78,964
2023-09-01 Crowley John F (Executive Chairman) Sale 6,044 12.98 78,445
2023-09-01 Campbell Bradley L (President & CEO) Sale 18,093 12.97 234,648
2023-09-01 Campbell Bradley L (President & CEO) Option Ex 11,700 2.94 34,398
2023-08-15 Crowley John F (Executive Chairman) Sale 6,044 13.03 78,735
2023-08-09 Prout Samantha (Chief Accounting Officer) Sale 36,909 14.01 516,947
2023-08-09 Prout Samantha (Chief Accounting Officer) Option Ex 36,909 10.43 385,071
2023-08-01 Crowley John F (Executive Chairman) Sale 6,044 13.36 80,717
2023-08-01 Campbell Bradley L (President & CEO) Sale 20,000 13.39 267,880
2023-08-01 Campbell Bradley L (President & CEO) Option Ex 11,700 2.94 34,398
2023-07-17 Crowley John F (Executive Chairman) Sale 6,044 13.45 81,261
2023-07-13 Campbell Bradley L (President & CEO) Sale 6,800 12.51 85,088
2023-07-12 Campbell Bradley L (President & CEO) Sale 1,500 12.51 18,759
2023-07-03 Crowley John F (Executive Chairman) Sale 6,044 12.31 74,407
2023-07-03 Campbell Bradley L (President & CEO) Sale 11,700 12.31 144,015
2023-07-03 Campbell Bradley L (President & CEO) Option Ex 11,700 2.94 34,398
2023-06-15 Crowley John F (Executive Chairman) Sale 6,044 13.04 78,813
2023-06-06 Campbell Bradley L (President & CEO) Sale 8,300 12.50 103,774
2023-06-01 Crowley John F (Executive Chairman) Sale 6,044 11.36 68,659
2023-06-01 Campbell Bradley L (President & CEO) Sale 11,700 11.36 132,947
2023-06-01 Campbell Bradley L (President & CEO) Option Ex 11,700 2.69 31,531
2023-05-18 Sblendorio Glenn (Director) Option Ex 15,000 3.32 49,800
2023-05-15 Crowley John F (Executive Chairman) Sale 6,044 11.18 67,577
2023-05-01 Crowley John F (Executive Chairman) Sale 6,044 11.80 71,337
2023-05-01 Campbell Bradley L (President & CEO) Sale 11,700 11.80 138,095
2023-05-01 Campbell Bradley L (President & CEO) Option Ex 11,700 2.45 28,665
2023-04-17 Crowley John F (Executive Chairman) Sale 6,044 11.66 70,503
2023-04-03 Crowley John F (Executive Chairman) Sale 6,044 11.22 67,789
2023-04-03 Campbell Bradley L (President & CEO) Sale 11,700 11.21 131,203
2023-04-03 Campbell Bradley L (President & CEO) Option Ex 11,700 2.45 28,665
2023-03-17 Raab Michael (Director) Sale 4,408 11.33 49,942
2023-03-17 Raab Michael (Director) Option Ex 15,000 3.32 49,800
2023-03-15 Crowley John F (Executive Chairman) Sale 12,088 11.34 137,090
2023-03-01 Crowley John F (Executive Chairman) Sale 6,044 13.49 81,521
2023-03-01 Campbell Bradley L (President & CEO) Sale 20,000 13.40 267,920
2023-03-01 Campbell Bradley L (President & CEO) Option Ex 11,700 2.45 28,665
2023-02-15 Crowley John F (Executive Chairman) Sale 6,044 12.94 78,215
2023-02-01 Crowley John F (Executive Chairman) Sale 147,316 13.11 1,931,312
2023-02-01 Crowley John F (Executive Chairman) Option Ex 139,929 5.62 785,701
2023-02-01 Campbell Bradley L (President & CEO) Sale 20,000 12.97 259,500
2023-02-01 Campbell Bradley L (President & CEO) Option Ex 11,700 2.45 28,665
2023-01-24 Rosenberg Ellen (Chief Legal Officer) Sale 31,839 13.32 423,999
2023-01-18 Clark David Michael (Chief People Officer) Sale 7,382 13.50 99,657
2023-01-18 Quimi Daphne (Chief Financial Officer) Sale 6,923 13.00 89,999
2023-01-17 Quimi Daphne (Chief Financial Officer) Sale 5,000 12.49 62,445
2023-01-13 Mcglynn Margaret G (Director) Sale 45,000 13.03 586,170
2023-01-13 Mcglynn Margaret G (Director) Option Ex 45,000 3.32 149,400
2023-01-09 Crowley John F (Executive Chairman) Sale 85,102 11.43 972,971
2023-01-09 Campbell Bradley L (President & CEO) Sale 11,700 11.43 133,754
2023-01-09 Campbell Bradley L (President & CEO) Option Ex 11,700 2.45 28,665
2023-01-03 Clark David Michael (Chief People Officer) Sale 16,986 12.03 204,358
2022-12-15 Crowley John F (Executive Chairman) Sale 10,468 12.15 127,175
2022-12-01 Crowley John F (Executive Chairman) Sale 22,694 12.20 276,956
2022-12-01 Campbell Bradley L (President & CEO) Sale 10,970 12.20 133,854
2022-12-01 Campbell Bradley L (President & CEO) Option Ex 10,970 3.53 38,724
2022-11-15 Crowley John F (Executive Chairman) Sale 10,468 11.64 121,868
2022-11-01 Crowley John F (Executive Chairman) Sale 11,346 10.32 117,056
2022-11-01 Campbell Bradley L (President & CEO) Sale 5,470 10.01 54,760
2022-11-01 Campbell Bradley L (President & CEO) Option Ex 5,470 3.53 19,309
2022-10-17 Crowley John F (Executive Chairman) Sale 10,468 10.90 114,153
2022-10-03 Crowley John F (Executive Chairman) Sale 11,346 10.75 121,924
2022-10-03 Campbell Bradley L (President & CEO) Sale 5,470 10.54 57,626
2022-10-03 Campbell Bradley L (President & CEO) Option Ex 5,470 3.53 19,309
2022-09-15 Crowley John F (Executive Chairman) Sale 10,468 10.66 111,630
2022-08-15 Crowley John F (Executive Chairman) Sale 10,468 12.28 128,588
2022-08-05 Clark David Michael (Chief People Officer) Sale 11,322 12.50 141,525
2022-08-05 Quimi Daphne (Chief Financial Officer) Sale 5,798 12.00 69,576
2022-08-01 Rosenberg Ellen (Chief Legal Officer) Sale 11,123 10.02 111,474
2022-08-01 Crowley John F (Executive Chairman) Sale 11,346 9.96 113,028
2022-08-01 Campbell Bradley L (President & CEO) Sale 5,470 10.03 54,880
2022-08-01 Campbell Bradley L (President & CEO) Option Ex 5,470 3.53 19,309
2022-07-15 Crowley John F (Chairman & CEO) Sale 10,468 10.86 113,672
2022-07-01 Crowley John F (Chairman & CEO) Sale 11,346 10.78 122,332
2022-07-01 Campbell Bradley L (Chief Operating Officer) Sale 5,470 10.72 58,616
2022-07-01 Campbell Bradley L (Chief Operating Officer) Option Ex 5,470 3.53 19,309
2022-06-21 Rosenberg Ellen (Chief Legal Officer) Sale 11,122 10.01 111,275
2022-06-21 Campbell Bradley L (Chief Operating Officer) Sale 16,410 10.00 164,100
2022-06-21 Campbell Bradley L (Chief Operating Officer) Option Ex 16,410 3.53 57,927
2022-06-17 Quimi Daphne (Chief Financial Officer) Sale 4,396 9.00 39,564
2022-06-15 Crowley John F (Chairman & CEO) Sale 10,468 8.01 83,838
2022-06-03 Crowley John F (Chairman & CEO) Sale 11,346 8.00 90,768
2022-05-23 Crowley John F (Chairman & CEO) Sale 21,814 8.00 174,577
2022-05-02 Raab Michael (Director) Sale 15,000 6.99 104,895
2022-05-02 Raab Michael (Director) Option Ex 15,000 4.79 71,850
2022-05-02 Mcglynn Margaret G (Director) Sale 15,000 6.99 104,895
2022-05-02 Mcglynn Margaret G (Director) Option Ex 15,000 4.79 71,850
2022-04-19 Crowley John F (Chairman & CEO) Sale 8,254 8.01 66,081

Insider trading activities including stock purchases, stock sales, and option exercises of FOLD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amicus Therapeutics, Inc. (symbol FOLD, CIK number 1178879) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.